MayumbineCAS# 25532-45-0 |
- Ajmalicine
Catalog No.:BCN5577
CAS No.:483-04-5
- Akuammigine
Catalog No.:BCN4607
CAS No.:642-17-1
- Tetrahydroalstonine
Catalog No.:BCN4189
CAS No.:6474-90-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 25532-45-0 | SDF | Download SDF |
PubChem ID | 179460 | Appearance | Powder |
Formula | C21H24N2O3 | M.Wt | 352.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 | ||
Standard InChIKey | GRTOGORTSDXSFK-XIEZEKGWSA-N | ||
Standard InChI | InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15+,16-,19+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Mayumbine (IC50 = 76 ± 3.5 nM) potently inhibit the in vitro binding of 3H-diazepam to the benzodiazepine sites within the rat GABAA receptor complex. |
Targets | GABA Receptor |
Mayumbine Dilution Calculator
Mayumbine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8377 mL | 14.1884 mL | 28.3768 mL | 56.7537 mL | 70.9421 mL |
5 mM | 0.5675 mL | 2.8377 mL | 5.6754 mL | 11.3507 mL | 14.1884 mL |
10 mM | 0.2838 mL | 1.4188 mL | 2.8377 mL | 5.6754 mL | 7.0942 mL |
50 mM | 0.0568 mL | 0.2838 mL | 0.5675 mL | 1.1351 mL | 1.4188 mL |
100 mM | 0.0284 mL | 0.1419 mL | 0.2838 mL | 0.5675 mL | 0.7094 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Z-Ile-Glu-Pro-Phe-Ome
Catalog No.:BCC5526
CAS No.:255257-97-4
- Isoferulic acid
Catalog No.:BCN5122
CAS No.:25522-33-2
- Ibotenic acid
Catalog No.:BCC6591
CAS No.:2552-55-8
- Bruceine A
Catalog No.:BCC5311
CAS No.:25514-31-2
- Bruceine C
Catalog No.:BCN8000
CAS No.:25514-30-1
- Bruceine B
Catalog No.:BCN7615
CAS No.:25514-29-8
- 1-Acetyl-4-piperidinecarboxylic acid
Catalog No.:BCC8447
CAS No.:25503-90-6
- 4-Phenylbutan-2-one
Catalog No.:BCN3808
CAS No.:2550-26-7
- 3-Epioleanolic acid
Catalog No.:BCN3050
CAS No.:25499-90-5
- Tasquinimod
Catalog No.:BCC1987
CAS No.:254964-60-8
- 4-Allyloxy-2-hydroxybenzophenone
Catalog No.:BCC8675
CAS No.:2549-87-3
- Kushenol X
Catalog No.:BCN3350
CAS No.:254886-77-6
- Propidium iodide
Catalog No.:BCC8015
CAS No.:25535-16-4
- 1-(4-Hydroxybenzoyl)glucose
Catalog No.:BCN6900
CAS No.:25545-07-7
- 7-Methoxy-4-methylcoumarin
Catalog No.:BCN6540
CAS No.:2555-28-4
- Efetaal
Catalog No.:BCN8494
CAS No.:2556-10-7
- 1,6,7-Trihydroxyxanthone
Catalog No.:BCN5124
CAS No.:25577-04-2
- Delta-Tocotrienol
Catalog No.:BCN6696
CAS No.:25612-59-3
- 7beta-Acetoxytaxuspine C
Catalog No.:BCN7219
CAS No.:256347-91-8
- BAY 41-2272
Catalog No.:BCC7932
CAS No.:256376-24-6
- SEW 2871
Catalog No.:BCC7312
CAS No.:256414-75-2
- Schleicheol 1
Catalog No.:BCN4661
CAS No.:256445-66-6
- Schleicheol 2
Catalog No.:BCN5125
CAS No.:256445-68-8
- Ac2-12
Catalog No.:BCC5826
CAS No.:256447-08-2
Main glucosidase conversion products of the gluco-alkaloids dolichantoside and palicoside.[Pubmed:11397430]
Phytochemistry. 2001 Jul;57(5):653-9.
The enzymatic glucose cleavage of palicoside revealed the biosynthetic pathway to akagerine, whereas the conversion of dolichantoside led to a new quaternary heteroyohimbine alkaloid named N(b)-methyl-21-beta-hydroxy-Mayumbine. The hypothetical models of reactions occurring after the conversion of both substrates are proposed. Dolichantoside and palicoside, as well as Strychnos mellodora stem bark crude ethanol extract, exhibit significant antimycotic activity against human pathogens in presence of specific glucosidase.